Overview
No overview information available.
Indication
用于各类急、慢性关节炎、风湿及类风湿性关节炎、骨关节炎、滑膜炎、肩周炎、老年性腰腿痛、软组织损伤及各类神经性疼痛与肿胀等症。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/03/10 | Phase 3 | Not yet recruiting | |||
2022/09/19 | Phase 1 | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Sinomenone Hydrochloride Enteric-coated Tablets | 国药准字H61022862 | 化学药品 | 片剂 | 6/5/2020 | |
| Sinomenone Hydrochloride Enteric-coated Tablets | 国药准字H61023665 | 化学药品 | 片剂(肠溶) | 8/18/2020 | |
| Sinomenone Hydrochloride Enteric-coated Tablets | 国药准字H37023717 | 化学药品 | 片剂 | 5/26/2020 | |
| Sinomenone Hydrochloride Enteric-coated Tablets | 国药准字H35021273 | 化学药品 | 片剂(肠溶片) | 8/4/2021 | |
| Sinomenone Hydrochloride Enteric-coated Tablets | 国药准字H51023710 | 化学药品 | 片剂 | 4/15/2020 | |
| Sinomenone Hydrochloride Enteric-coated Tablets | 国药准字H41025114 | 化学药品 | 片剂 | 6/19/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.